Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Meyronet

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Therapeutic Advances in Neurological Disorders|November 3, 2025
Clinical and tumor features of patients with immune checkpoint inhibitor-related neurological disorders and anti-Yo antibodiesAntonio Farina, Elise Peter, Nolwenn Billet, et al.
Oncotarget|April 21, 2017
Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4Amélie Royet, Laura Broutier, Marie-May Coissieux, et al.
Plos One|April 21, 2016
Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological CorrelationsGuillaume Marzolf, Marcela Sabou, Béatrice Lannes, et al.
Neuro-Oncology|February 16, 2017
Characteristics of H3 K27M-mutant gliomas in adultsDavid Meyronet, Maud Esteban-Mader, Charlotte Bonnet, et al.
European Journal of Neurology|May 19, 2023
T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy aloneInés Esparragosa Vazquez, Mané Ndiaye, Anna Luisa Di Stefano, et al.
JAMA Neurology|January 7, 2015
Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob diseaseAline Dorey, Yannick Tholance, Alain Vighetto, et al.
Journal of Neurochemistry|September 27, 2014
COB231 targets amyloid plaques in post-mortem human brain tissue and in an Alzheimer mouse modelDominique Garin, Angélique Virgone-Carlotta, Bülent Gözel, et al.
Pediatric Research|June 22, 2026
A quest for a histaminergic or orexinergic biomarker for sudden infant death syndromeYan Zhao, Guang-Fu Cui, Sabine Plancoulaine, et al.
Brain Pathology (Zurich, Switzerland)|October 5, 2017
Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular featuresFranck Bielle, Anna-Luisa Di Stefano, David Meyronet, et al.
Biomedical Optics Express|April 13, 2022
Brain virtual histology with X-ray phase-contrast tomography Part I: whole-brain myelin mapping in white-matter injury modelsMatthieu Chourrout, Hugo Rositi, Elodie Ong, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Therapeutic Advances in Neurological Disorders|November 3, 2025
Clinical and tumor features of patients with immune checkpoint inhibitor-related neurological disorders and anti-Yo antibodiesAntonio Farina, Elise Peter, Nolwenn Billet, et al.
Oncotarget|April 21, 2017
Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4Amélie Royet, Laura Broutier, Marie-May Coissieux, et al.
Plos One|April 21, 2016
Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological CorrelationsGuillaume Marzolf, Marcela Sabou, Béatrice Lannes, et al.
Neuro-Oncology|February 16, 2017
Characteristics of H3 K27M-mutant gliomas in adultsDavid Meyronet, Maud Esteban-Mader, Charlotte Bonnet, et al.
European Journal of Neurology|May 19, 2023
T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy aloneInés Esparragosa Vazquez, Mané Ndiaye, Anna Luisa Di Stefano, et al.
JAMA Neurology|January 7, 2015
Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob diseaseAline Dorey, Yannick Tholance, Alain Vighetto, et al.
Journal of Neurochemistry|September 27, 2014
COB231 targets amyloid plaques in post-mortem human brain tissue and in an Alzheimer mouse modelDominique Garin, Angélique Virgone-Carlotta, Bülent Gözel, et al.
Pediatric Research|June 22, 2026
A quest for a histaminergic or orexinergic biomarker for sudden infant death syndromeYan Zhao, Guang-Fu Cui, Sabine Plancoulaine, et al.
Brain Pathology (Zurich, Switzerland)|October 5, 2017
Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular featuresFranck Bielle, Anna-Luisa Di Stefano, David Meyronet, et al.
Biomedical Optics Express|April 13, 2022
Brain virtual histology with X-ray phase-contrast tomography Part I: whole-brain myelin mapping in white-matter injury modelsMatthieu Chourrout, Hugo Rositi, Elodie Ong, et al.
Pageof 14